Atorvastatin
آتورواستاتین
❤️ Cardiovascular SystemStatin
Market / country: 🇺🇸 USA
Lipitor (US)
🧮 Dose calculator
Hyperlipidemia / heterozygous familial hypercholesterolemia · Regimen source: FDA Atorvastatin · 2.3FDA Atorvastatin · 8.4
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Acute liver failure or decompensated cirrhosis; hypersensitivity. FDA Atorvastatin · 4
Formulations
- 10 mg tablet — tablet 🇺🇸 USA FDA Atorvastatin · 3
- 20 mg tablet — tablet 🇺🇸 USA FDA Atorvastatin · 3
- 40 mg tablet — tablet 🇺🇸 USA FDA Atorvastatin · 3
- 80 mg tablet — tablet 🇺🇸 USA FDA Atorvastatin · 3
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Atorvastatin · 8.1
“Atorvastatin calcium decreases synthesis of cholesterol and possibly other biologically active substances derived from cholesterol; therefore, atorvastatin calcium may cause fetal harm when administered to pregnant patients based on the mechanism of action [see Clinical Pharmacology (12.1) ].”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Atorvastatin · 8.2
“Because of the potential for serious adverse reactions in a breastfed infant, based on the mechanism of action, advise patients that breastfeeding is not recommended during treatment with atorvastatin calcium [see Use in Specific Populations (8.1) , Clinical Pharmacology (12.1) ] .”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Atorvastatin · 8.4
“The safety and effectiveness of atorvastatin calcium as an adjunct to diet to reduce LDL-C have been established pediatric patients 10 years of age and older with HeFH.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Atorvastatin · 8.5
“Dose selection for an elderly patient should be cautious, recognizing the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy and the higher risk of myopathy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA205519
- DailyMed (FDA label)FDA Atorvastatin
- MedlinePlus (NIH)Atorvastatin
- WHO ATC/DDDC10AA05
- Darooyab (Iran)Atorvastatin
🇮🇷 Registered in Iran Darooyab · G-1537/Atorvastatin
Dosage forms with Iranian generic codes, per Darooyab.
- 01910 · ATORVASTATIN 10MG TAB · قرص آتورواستاتین ۱۰ میلیگرم
- 01911 · ATORVASTATIN 20MG TAB · قرص آتورواستاتین ۲۰ میلیگرم
- 01912 · ATORVASTATIN 40MG TAB · قرص آتورواستاتین ۴۰ میلیگرم
- 16350 · ATORVASTATIN 80MG TAB · قرص آتورواستاتین ۸۰ میلیگرم
- 52871 · ATORVASTATIN (AS CALCIUM) TABLET ORAL 80 mg · قرص آتورواستاتین (معادل کلسیم) ۸۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Atorvastatin · 3FDA Atorvastatin · 2.3FDA Atorvastatin · 8.4FDA Atorvastatin · 2.2FDA Atorvastatin · 2.1FDA Atorvastatin · 4FDA Atorvastatin · 8.1FDA Atorvastatin · 8.2FDA Atorvastatin · 8.5FDA Atorvastatin · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1537/Atorvastatin
- Clinical review⚠ Unverified